A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety

Eric Mallet,Bernd H. Belohradsky,Rosanna Lagos,Leif Gothefors,Patrice Camier,Jean-Pierre Carriere,Kanra G,Agnes Hoffenbach,Jacques Langue,François Undreiner,François Roussel,Philippe Reinert,Carl-Erik Flodmark,Silvia Stojanov,Johannes G. Liese,Myron M. Levine,Alma Muñoz,Florian Schödel,Luc Hessel

A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety

2004

Eric Mallet
Bernd H. Belohradsky
Rosanna Lagos
Leif Gothefors
Patrice Camier
Jean-Pierre Carriere
Kanra G
Agnes Hoffenbach
Jacques Langue
François Undreiner
François Roussel
Philippe Reinert
Carl-Erik Flodmark
Silvia Stojanov
Johannes G. Liese
Myron M. Levine
Alma Muñoz
Florian Schödel
Luc Hessel

To reduce the number of injections needed to comply with paediatric vaccination requirements, a liquid, hexavalent vaccine (DTaP-IPV-PRP-T-HBs; Hexavac; Aventis Pasteur MSD) has been developed for ...

Keywords:

Haemophilus influenzae
Hepatitis B
Tetanus
Hepatitis B vaccine
Whooping cough
Virology
Immunogenicity
Immunology
Diphtheria
Medicine
Vaccination
Poliomyelitis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations